Terns Pharmaceuticals Inc. buy BiotechBee
Start price
24.06.23
/
60%
€8.87
Target price
31.12.25
€18.00
Performance (%)
-45.26%
End price
01.10.23
€4.86
Summary
This prediction ended on 01.10.23 with a price of €4.86. Massive losses of -45.26% were the result for the BUY prediction by BiotechBee. BiotechBee has a follow-up prediction for Terns Pharmaceuticals Inc. where he still thinks Terns Pharmaceuticals Inc. is a Buy. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Terns Pharmaceuticals Inc. | -9.559% | -9.559% | 14.953% |
iShares Core DAX® | 0.393% | -2.618% | 11.310% |
iShares Nasdaq 100 | 0.394% | -10.309% | 23.697% |
iShares Nikkei 225® | 1.038% | -8.365% | 7.878% |
iShares S&P 500 | -0.046% | -4.991% | 21.704% |
According to BiotechBee what are the pros and cons of Terns Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Terns Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 18,0
In the thread Trading Terns Pharmaceuticals Inc.
Buy beendet
Current prediction by BiotechBee for Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.85
22.06.24
22.06.24
€10.00
30.04.26
30.04.26
-11.68%
08.08.24
08.08.24
Could be very worthwhile Investment >20% year